Assistant Professor of Gynecologic Oncology at Northwestern Medicine. The views expressed here are my own.
Joined March 2018
- Tweets 157
- Following 229
- Followers 586
- Likes 874
41 Photos and videos
Emily Hinchcliff retweeted
23 Aug 2023
Robert H. Lurie Comprehensive Cancer Center at Northwestern University and the Northwestern Medicine Division of Gynecologic Oncology are hosting Survive and Thrive on Friday, September 29. This program shares the latest advances in cancer therapies, survivorship and supportive care methodology. In addition, patients and caregivers can engage with experts in gynecologic cancer.
Register now: eventbrite.com/e/survive-and…
2
8
897
Emily Hinchcliff retweeted
25 Mar 2023
1
38
2,152
15 Oct 2022
What an awesome hands-on skills session at the @SGO_org Allied Health meeting. So great to get to help out, and also get to see friends in the process! #sgomtg @LurieCancer @MDAndersonNews @DrKMills
1
2
20
7 Oct 2022
Honored to open the endometrial cancer updates session! Excellent further updates now ongoing from @DarioRoqueMD and Dr Alok Pant
7 Oct 2022
@HinchcliffEmily making science interesting and teaching us about molecular classification in endometrial cancer. #NMsurviveandthrive2022 #gyncancer #endometrialcancer #NMGynOnc
1
19
Emily Hinchcliff retweeted
7 Oct 2022
Dr. Siobhan Phillips teaching us all about getting healthy and staying physically active. #NMsurviveandthrive2022 #NMGynOnc #sitlessandmovemore
2
9
Emily Hinchcliff retweeted
6 Oct 2022
Looking forward to tomorrow’s Survive & Thrive program for people with #gynecologiccancer — past or present — and those at increased risk, along with their families & caregivers. View the list of experts and the topics they’ll discuss: cancer.northwestern.edu/docs…
6 Oct 2022
Robert H. Lurie Comprehensive Cancer Center and the Northwestern Medicine Division of Gynecologic Oncology are hosting Survive & Thrive on Friday, October 7. This is an interactive course for people living with gynecologic cancer. Register now: planitpurple.northwestern.ed…
2
4
Emily Hinchcliff retweeted
28 Sep 2022
Join us Fri. Oct. 7 for an interactive discussion with our experts! Women with #gynecologiccancer-past or present-as well as those at increased risk, families & caregivers, are invited to register. Check out the details at: cancer.northwestern.edu/even… #gyncsm
4
4
19 Aug 2022
Such a great discussion during the @NM_ObGyn @NU_ObGynRes summer series about social media in professional development! Honored to weigh in next to all 🌟s @drevefeinberg @AngChaudhariMD
3
1
38
Emily Hinchcliff retweeted
18 Aug 2022
MD Anderson is grateful to CPRIT for providing $2.5 million to support expansion of cervical cancer prevention services to rural and medically underserved populations.
bit.ly/3CdUzqP
@CPRITTexas @KMSchmeler #EndCancer
1
7
32
17 Jun 2022
🌟All-star graduating fellow @AllisonSaizMD presents @NU_ObGynRes research day: @SGO_org provider reported patterns re: surgical management of early cervical cancer. Controversy remains in practice! @edtanner @EmmaBarberMD @daroque22 @JMarcusMD @matei_dem
22
Emily Hinchcliff retweeted
17 Jun 2022
We are so excited to be celebrating our Annual Resident and Fellow Research Day in person this year after 2 long years!
1
19
Emily Hinchcliff retweeted
4 Jun 2022
Congrats to @LaurenPCobb for her #ASCO22 abstract on use of non-chemo regimen for neoadjuvant tx of advanced low grade #ovarian cancer! Exceptional responses in hard to treat disease @AmirJazaeri @RareOvarCancers #oncsurgery @MDAndersonNews
2
15
60
21 Mar 2022
Honored to present these results! Providing the foundation for exciting mechanistic work and trial options @AmirJazaeri @MDAndersonNews
21 Mar 2022
@HinchcliffEmily on clear cell #OvarianCancer: PPP2R1A mutations consistently assoc w/ improved survival when treating with immune checkpoint inhibitors may be a prognostic biomarker and possible target (drug/trial option coming soon!)
#SGOMtg
1
4
26
Emily Hinchcliff retweeted
21 Mar 2022
Incredible findings from
@MDAndersonNews
at #SGO2022. PPP2R1A mutation in platinum-resistant ovarian clear cell carcinoma predicts exceptional survival when treated with CTLA-4 and PD-1 checkpoint inhibitors.
@HinchcliffEmily @AmirJazaeri
#SGOmtg
4
15
Emily Hinchcliff retweeted
19 Mar 2022
Assoc Editor Gyn Onc @RauhHainMD describes important components of #database #studies @gynoncjnls @SGO_org #SGO2022 #Evaluecalculator
6
15
Emily Hinchcliff retweeted
19 Mar 2022
Our fellow Deanna Glassman presenting her innovative and novel AI model to help predict response to therapy in HGSOC. So proud! #SGOmtg @AnilSoodMD @karenluMD @maonstad @Frumovitz
4
18
Emily Hinchcliff retweeted
18 Mar 2022
Deanna Glassman giving an awesome @SGO plenary talk on strategy of overcoming bevacizumab resistance with glutaminase inhibitor for ovarian cancer!!! Congrats to her and mentor @AnilSoodMD !! #oncsurgery #SGOmtg @MDAndersonNews
8
36
11 Feb 2022
#NRG2022: excellent science, mentorship, and the opportunity to call out/congratulate your friends for being social media influencers @katiekurnit @BeccaPrevisMD @GOG @NRGonc #internationalwomeninscienceday
1
9
